Display options
Cite
Axelsen M, Smith Pedersen R, Heaf JG, et al. Mesangioproliferative glomerulonephritis: a 30-year prognosis study. Nephron Extra. 2014;4(1):26-32doi: 10.1159/000360364.
Axelsen, M., Smith Pedersen, R., Heaf, J. G., & Ellingsen, T. (2014). Mesangioproliferative glomerulonephritis: a 30-year prognosis study. Nephron extra, 4(1), 26-32. https://doi.org/10.1159/000360364
Axelsen, Mette, et al. "Mesangioproliferative glomerulonephritis: a 30-year prognosis study." Nephron extra vol. 4,1 (2014): 26-32. doi: https://doi.org/10.1159/000360364
Axelsen M, Smith Pedersen R, Heaf JG, Ellingsen T. Mesangioproliferative glomerulonephritis: a 30-year prognosis study. Nephron Extra. 2014 Mar 07;4(1):26-32. doi: 10.1159/000360364. eCollection 2014 Jan. PMID: 24715900; PMCID: PMC3977227.
Copy Download .nbib Format: NLM
Share it on

Nephron Extra. 2014 Mar 07;4(1):26-32. doi: 10.1159/000360364. eCollection 2014 Jan.

Mesangioproliferative glomerulonephritis: a 30-year prognosis study.

Nephron extra

Mette Axelsen, Robert Smith Pedersen, James Goya Heaf, Torkell Ellingsen

Affiliations

  1. Institute of Public Health, Aarhus University, Aarhus, Denmark ; Department of Internal Medicine, Ribe County Hospital, Esbjerg, University of Copenhagen, Copenhagen, Denmark ; Diagnostic Center, Regionhospital Silkeborg, Silkeborg, Denmark.
  2. Department of Internal Medicine, Ribe County Hospital, Esbjerg, University of Copenhagen, Copenhagen, Denmark.
  3. Department of Nephrology B, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
  4. Institute of Public Health, Aarhus University, Aarhus, Denmark ; Diagnostic Center, Regionhospital Silkeborg, Silkeborg, Denmark.

PMID: 24715900 PMCID: PMC3977227 DOI: 10.1159/000360364

Abstract

BACKGROUND: Diffuse mesangioproliferative glomerulonephritis (MesP) is the most commonly diagnosed type of glomerulonephritis (GN) in Denmark, with an incidence of 10.8 million per year. In the present study, the 30-year renal survival was estimated.

METHODS: A retrospective cohort investigation of 140 patients with biopsy-proven MesP was performed between the period 1967-2006. Factors influencing renal survival were investigated using Cox regression analysis.

RESULTS: Renal survival at 5, 10, 20 and 30 years was 87, 78, 59 and 50%, respectively. Female survival after 30 years was significantly better than male survival (70 vs. 40%, p = 0.049). Multivariate analysis, adjusted for age, estimated glomerular filtration rate (GFR) and nephrotic syndrome (NS) was performed for each sex individually. An increase in GFR was associated with a hazard risk (HR) of 0.98 (p = 0.02) in women and 0.99 (p = 0.006) in men. Older age was associated with a HR of 1.04 (p = 0.02) in women and 1.03 (p = 0.004) in men. NS had a poorer prognosis in men (HR 2.53, p = 0.01), but not in women (HR 0.54, p = 0.38).

CONCLUSION: Increasing age and decreasing GFR were adversely associated with renal death. Renal prognosis was better for women after 30 years, and NS resulted in a poorer prognosis in men. This suggests that disease course and prognosis are different between men and women.

Keywords: Cox regression analysis; Primary diffuse mesangioproliferative glomerulonephritis; Prognostic factors; Renal survival

References

  1. Pathol Res Pract. 1992 Oct;188(7):908-24 - PubMed
  2. Am J Kidney Dis. 1997 Apr;29(4):526-32 - PubMed
  3. Q J Med. 1991 Apr;79(288):333-50 - PubMed
  4. Nephrol Dial Transplant. 1999 Aug;14(8):1889-97 - PubMed
  5. Nephrol Dial Transplant. 2009 Oct;24(10):3050-4 - PubMed
  6. Ann Intern Med. 2006 Aug 15;145(4):247-54 - PubMed
  7. Clin Chem. 2008 Mar;54(3):559-66 - PubMed
  8. Nephrol Dial Transplant. 2002 Sep;17(9):1603-13 - PubMed
  9. Scand J Urol Nephrol. 1995 Sep;29(3):265-72 - PubMed

Publication Types